PsA: Meta-analysis demonstrates low rate of opportunistic infections with bDMARDs and tsDMARDsOctober 25, 2022Psoriatic Arthritis
Meta-analysis demonstrates efficacy of JAK inhibitors in treating PsAOctober 25, 2022Psoriatic Arthritis
PsA: Tofacitinib reduces pain by improving itch and other symptomsOctober 25, 2022Psoriatic Arthritis
PsA: Guselkumab is a promising therapeutic option in the real worldOctober 25, 2022Psoriatic Arthritis
RA: Higher rehabilitation dose improves patient-reported physical function in real worldOctober 25, 2022Rheumatoid Arthritis
RA: High serum IFNβ levels predict early relapse after bDMARD withdrawalOctober 25, 2022Rheumatoid Arthritis
Patients with RA remain at higher risk for SARS-CoV-2 infection and severe outcomesOctober 25, 2022Rheumatoid Arthritis
